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Abstract
Life-long regeneration of healthy muscle by cell transplantation is an ideal therapy for patients with degenerative
muscle diseases. Yet, obtaining muscle stem cells from patients is very limited due to their exhaustion in disease
condition. Thus, development of a method to obtain healthy myogenic stem cells is required. Here, we showed that
the four transcription factors, Six1, Eya1, Esrrb, and Pax3, converts ﬁbroblasts into induced myogenic stem cells (iMSCs).
The iMSCs showed effective differentiation into multinucleated myotubes and also higher proliferation capacity than
muscle derived stem cells both in vitro and in vivo. The iMSCs do not lose their proliferation capacity though the
passaging number is increased. We further isolated CD106-negative and α7-integrin-positive iMSCs (sort-iMSCs)
showing higher myogenic differentiation capacity than iMSCs. Moreover, genome-wide transcriptomic analysis of
iMSCs and sort-iMSCs, followed by network analysis, revealed the genes and signaling pathways associated with
enhanced proliferation and differentiation capacity of iMSCs and sort-iMSCs, respectively. The stably expandable iMSCs
provide a new source for drug screening and muscle regenerative therapy for muscle wasting disease.
Introduction
Dysfunction of muscle stem cells causes muscle dis-
eases. Although there is much progress in understanding
the genetic defects in degenerative muscle diseases, the
diseases remain incurable. Therefore, the transplantation
of stem cells to damaged muscle tissue has been con-
sidered as an ideal therapeutic strategy.
Autologous stem cell transplantation is by far the most
common stem cell transplantation. In degenerative mus-
cle diseases, however, application of muscle derived stem
cells (MDSC) from patients has been technically chal-
lenging. It is very hard to isolate myoblasts or satellite
cells from muscular dystrophy or sarcopenia patients, as
these patients show difﬁculties in regenerating muscle and
have less muscle than normal individuals. Additionally,
muscle laceration for sampling is very invasive, especially
in case of patients with muscular dystrophy or sarcopenia.
Further, MDSCs, as multipotent, have the differentiation
capacity that is not conﬁned only to myogenesis, but also
to adipogenesis, chondrogenesis and osteogenesis1. An
animal study also showed that satellite cells under aging
become ﬁbrogenic rather than myogenic via the activation
of Wnt signaling2. Thus, a new source for myogenic stem
cells that can be used in stem cell therapy is necessary.
It has been revealed that terminally differentiated
somatic cells can be directly converted into totally dif-
ferent cell types by forcing ectopic expression of speciﬁc
transcription factors (TFs), referred to as direct conver-
sion. Various cell types, including neurons3,4, hepato-
cytes5,6, cardiomyocytes7–9, and blood progenitor cells10
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were induced from completely different somatic cells
using tissue-speciﬁc TFs.
The concept that ectopic expression of cell type-speciﬁc
genes alters cell properties was ﬁrst reported by Davis
et al.11 in 1987. They revealed that transfected MyoD
cDNA converts C3H10T1/2 embryonic ﬁbroblasts into
myoblasts. MyoD, a well-known muscle speciﬁc TF,
converts primary cells including dermal ﬁbroblasts,
chondroblasts, smooth muscle, and retinal pigmented
epithelial cells into myoblasts and myotubes12. Also, Liu
et al. suggested that ectopic expression of MyoD and
Cx43 make ﬁbroblasts differentiate into muscle ﬁbers13.
MyoD can induce myogenic differentiation from non-
myogenic cells. However, MyoD inhibits proliferation of
these transdifferentiated cells and these cells do not have
self-renewing and expansion capacities. The proliferation
capacity is important for the use of the generated cells
because sufﬁcient cells are required for cell transplanta-
tion and drug screening. No studies have established
stably expandable myogenic stem cells by direct repro-
gramming, although Naoki et al. induced myogenic pro-
genitor cells with the combination of six transcription
factors14.
Sine Oculis (Six1) plays a critical role in muscle devel-
opment. Loss of Six1 leads to lethality of fetus. The fetuses
of Six1 mutant mice exhibit impaired primary myogenesis
and muscle defects in the diaphragm, forelimb, and hin-
dlimb15. Overexpression of Six1 increases the expression
of Pax316. Six1 promotes the proliferation of Pax7 (+ )
cells by upregulating Smad1/5/817. Eyes absent1 (Eya1)
functions as a cofactor of Six1 to activate Six1 target genes
including Pax3, MyoD and myogenin18,19. Eya1/Eya2
mutant mice show delayed myogenesis during develop-
ment18. Estrogen related receptor beta (Esrrb) is a TF that
upregulates the self-renewal of trophoblasts and
embryonic stem cells20,21. Paired box 3 (Pax3) plays a
crucial role in the formation of ventro-lateral dermo-
myotome, which develops into the hypaxial body and limb
muscle during the development22–24.
In this study, by using a novel combination of these four
TFs involved in myogenesis or self-renewal, we have
established stably expandable induced myogenic stem
cells from ﬁbroblasts and revealed its in vitro and in vivo
proliferation and myogenic differentiation capacity.
Materials and methods
Lentivirus preparation
The Six1 open reading frame was subcloned into the
pLJM lentiviral vector (Addgene no. 19319), which have a
puromycin resistance gene. Eya1 and Pax3 were sub-
cloned into the FUW-tet-O plasmid (Addgene no. 20321).
A plasmid containing Esrrb (Addgene no. 40798) was
purchased from Addgene. A total of 5 × 106 of 293
FT cells were plated onto a 100 mm dish. When the 293
FT cells were 90% conﬂuent, they were transfected with 3
µg of lentiviral vector delivered by 36 µL Lipofectamine
2000 (Invitrogen), 5 mL of opti-MEM, and 9 µg of Vira-
Power lentiviral packaging mixture (Invitrogen). Viral
supernatant was harvested 48 h after transfection, cen-
trifuged at 3000 rpm for 15min at 4 °C, and ﬁltered
through a 0.45 µM ﬁlter (Millipore). The titration of
viruses was greater than 5 × 105 IFU/mL according to
measurement with Lenti-X GoStix (Clontech).
Establishment of iMSCs
To isolate mouse embryonic ﬁbroblasts (MEFs), mouse
embryos (C57BL/6J) were isolated from the uterus of
pregnant female mice at E13.5 days. Head and red organs
were eliminated and remaining whole body parts were cut
and minced. The minced tissues were incubated for 10
min at 37 °C with 0.05% of trypsin-EDTA for enzymatic
digestion and then the enzyme was neutralized. The pellet
was suspended in media and ﬁltered through 0.45 µm
ﬁlters MEFs were maintained in MEF media (10% fetal
bovine serum (FBS), 1% penicillin/streptomycin in high
glucose DMEM). The MEFs were maintained until pas-
sage 3 and seeded at 5 × 104. The MEFs were incubated
with Six1 lentivirus for 48 h. Two days after transduction,
the culture media was replaced with 1.5 mL of myogenic
growth media (10% FBS, 10% horse serum, 5 ng/mL
murine basic ﬁbroblast growth factor (FGF) and 1%
penicillin/streptomycin in high glucose DMEM) and the
cells were treated with 5 µg/mL puromycin for the next
25 days. The media was changed every 2 days. After ﬁn-
ishing puromycin selection, the Six1 transduced cells were
seeded at 5 × 104 and transduced with the lentivirus of
Esrrb, Eya1, and Pax3. After 48 h of transduction with
lentivirus of Esrrb, Eya1, and Pax3, the media containing
lentivirus was replaced with myogenic growth media. The
cells were maintained for 7 days with doxycycline (2 µg/
mL) to turn on the tet-O system. When the cells showed
robust proliferation, single-cell sorting was performed
using the FACS Aria and single-cell lines were established.
Each single-cell line was propagated and after cell growth
and RNA puriﬁcation, PCR was performed for Pax7 and
Myf5.
Real-time reverse transcriptase-polymerase chain reaction
(real-time RT-PCR) analysis
RNA was isolated using Trizol following the manu-
facturer’s protocol. cDNA was synthesized using 0.5 µg of
the RNA with reverse transcriptase (Invitrogen). For real-
time RT-PCR, 2 × SYBR Green PCR mastermix was used.
The primers for Pax7 (QT00147728), Myf5 (QT00199507),
MyoD (QT00101983), myogenin (QT00112378), MHC
(QT0106850), and GAPDH (QT01658692) were purchased
from Qiagen. Rotorgene Q (Qiagen) was used to perform
real-time RT-PCR and analyze the results.
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Immunoﬂuorescence (IF)
Cells were grown on 2% gelatin-coated multi-well
plates and ﬁxed for 15 min at room temperature in 4%
paraformaldehyde. After aspirating ﬁxative and washing
with phosphate-buffered saline (PBS), samples were
incubated for 10 min at −20 °C in 100% methanol for
permeabilization and then rinsed three times with PBS
for 5 min each. Samples were then blocked for 1 h at
room temperature with 5% BSA. After aspirating the
blocking buffer, the samples were incubated with pri-
mary antibodies against Pax7 (1:50, Developmental
Studies Hybridoma Bank), Myf5 (1:200, Santa Cruz),
MyoD (1:100, Santa Cruz), myogenin (1:25, Develop-
mental Studies Hybridoma Bank), and MHC (1:100,
Santa Cruz) for overnight at 4 °C. The samples were
rinsed three times with PBS for 5 min each. The samples
were incubated in alexar ﬂuor 594- or TRITC-
conjugated secondary antibodies (1:400) for 1 h at
room temperature. For counter staining, the samples
were incubated in 4′, 6-diamidino-2-phenylindole
(DAPI) for 10 min and mounted with coverslip.
Immunoblot analysis
Cells were washed with cold PBS and harvested with
RIPA buffer containing complete protease inhibitor
cocktail (Roche). Protein concentration was measured
according to the Bradford method25. Next, 50 µg of total
protein was incubated at 100 °C for 10min with electro-
phoresis sample buffer. The samples were loaded on each
well and separated by 6–20% SDS-polyacrylamide gel.
Proteins were transferred to a polyvinylidene diﬂuoride
(PVDF) membrane. The blot was blocked with 5% skim
milk for 1 h at room temperature and incubated overnight
at 4 °C with primary antibodies against Six1 (1:1000, Cell
Signaling), Eya1 (1:500, Abcam), Pax3 (1:500, R&D Sys-
tems), Esrrb (1:1000, R&D Systems), GRB2 (1:1000, Santa
Cruz), and GAPDH (1:2000, Cell Signaling). After incu-
bation with secondary antibodies (1:2000, Cell Signaling)
conjugated to horseradish peroxidase, signals were
detected by Super Signal West Dura Extended Duration
Substrate (Pierce). The signals were visualized using an
Image Analyzer (UVP) or exposed to medical X-ray ﬁlm.
Myogenic differentiation in vitro
To evaluate myogenesis in vitro, cells were seeded onto
a 2% gelatin-coated dish and incubated until the cells
occupied 90% of the culture dish area. Next, the dishes
were washed with PBS and the media was changed to
myogenic differentiation media. The myogenic differ-
entiation media contained 2% horse serum and 1% peni-
cillin/streptomycin in low-glucose DMEM. Cells were
incubated for 3 days in myogenic differentiation media.
The media was changed every day. Differentiated cells
were analyzed by real-time RT-PCR and IF.
Proliferation test in vitro
To evaluate proliferation capacity, 3 × 104 cells were
seeded onto a 2% gelatin-coated dish. The trypsinized
cells were stained with trypan blue. The number of cells
was counted every 24 h using a hemocytometer and try-
pan blue. This experiment was repeated three times.
Animals
Mice were maintained in a room at 22 ± 3 °C, relative
humidity 50 ± 10%, and 12 h light-dark cycle and were given
food and water ad libitum. Animal experiments were per-
formed in accordance with the NIH guidelines for the care
and use of laboratory animals and approved by institutional
animal care and use committee of Kyungpook National
University (Approval no. 2014–0167).
Myogenic differentiation in vivo
For in vivo myogenic differentiation analysis, 4-weeks-
old male mdx mice were used in vivo. We injected notexin
into the middle of tibialis anterior (TA) muscle at a dose
of 50 µg to injure the muscle one day before cell trans-
plantation. The iMSCs were prepared and 30,000 cells
were suspended in 20 µL of PBS. The cells were trans-
planted using an insulin syringe. The tibialis anterior
muscle was harvested from mice 4 weeks after cell
transplantation. To detect dystrophin, staining was per-
formed as previously described26. Brieﬂy, frozen sections
were blocked overnight at 4 °C with 10% horse serum in
PBS, and then probed overnight at 4 °C with rabbit anti-
dystrophin antibody (Abcam, 1:100). TRITC-conjugated
anti-rabbit IgG was used as the secondary antibody
(Invitrogen, 1:400). Images were obtained by confocal
ﬂuorescence microscopy.
Intravital imaging of iMSCs
pWPXL-based lentiviral vector expressing tdTomato
(here after Tomato) was kindly provided by Xiang Zhang
from Baylor College Medical School. To generate iRFP670-
expressing lentivirus, the EGFP gene in pWPXL lentiviral
vector (Addgene) was removed by BamHI/EcorRI digestion
and full-length iRFP670 from the piRFP670 plasmid
(Addgene) obtained by BamHI/MfeI digestion was cloned
into BamHI/EcorRI sites of pWPXL. pWPXL-based lenti-
virus was produced using HEK 293T cells. To visualize
transplanted iMSCs in muscle regeneration, in vitro cul-
tured MDSCs and iMSCs were transduced with iRFP670-
expressing lentivirus or tdTomato-expressing lentivirus
respectively. Tomato+ iMSCs and iRFP670+ MDSCs were
sorted by FACS and expanded for transplantation analysis.
Muscle injury and stem cell transplantation was performed
as described previously27,28 with minor modiﬁcations.
Brieﬂy, right TA muscle was injured with 50 μl of barium
chloride (1.2%) with 10–20 multiple needle punctures for
stem cell transplantation. Twenty-four hours after injury,
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in vitro cultured Tomato+ iMSCs and iRFP670+ MDSCs
and iMSCs (1 × 105/50 µL) were transplanted into injured
muscle. To sequentially image the muscle after cell
engraftment in vivo, mice were anesthetized and prepared
for customized multiphoton/confocal hybrid microscope
system (Leica TCS SP8 MP platform) speciﬁcally designed
for live animal imaging as described previously29. After the
mouse was mounted on a motorized stage, the exposed and
injured TA muscle was scanned for second harmonic
generation (SHG by femto-second titanium:sapphire laser
pulses tuned to 880 nm: Chameleon Vision Laser, Coher-
ent) from muscle ﬁbers. Tomato- (554 nm excitation, 581
nm detection) or iRFP670-expressing cells (630 nm excita-
tion, 670 nm detection) in combination with myoﬁbers
(440 nm s harmonic signals) were simultaneously imaged by
intravital microscopy. To identify the imaging location of
the TA muscle and to repeat the imaging sequentially, the
xyz coordinates of imaging position from the lateral tibia
head (a landmark position) were recorded.
Tumor formation assay
Six-week-old male nude mice (balb/c nu/nu mice) were
used in this assay. First, 5 × 106 iMSCs and iPSCs were
suspended in PBS. The cells were injected subcutaneously
into the dorsal part of the nude mice. After 3 weeks, mice
were sacriﬁced and the tumor tissues from the injected
site were isolated for histopathological analysis. Tumor
tissues were ﬁxed in 10% neutral-buffered formalin, pro-
cessed routinely, and embedded in parafﬁn wax. The
sections were cut to 4-µm thickness and then depar-
afﬁnized in toluene and rehydrated in a graded alcohol
series. The sections were stained with hematoxylin and
eosin (H&E).
mRNA microarray experiments
Total RNA was isolated from MEFs, MDSCs, iMSCs,
and sort-ﬁMSC cells using the RNeasy mini kit (Qiagen).
RNAs were obtained from two independent biological
replicates. RNA integrity was assessed using the Agilent
2100 Bioanalyzer, and RNA integrity numbers for all
samples were above 8.0. RNA was reverse-transcribed,
ampliﬁed, and hybridized to the Agilent SurePrint G3
mouse GE 8 × 60 K microarray, including 62,976 probes
corresponding to 23,853 genes, according to Agilent’s
protocols. Probe intensities were obtained using the
Agilent G2565BA microarray scanner and then normal-
ized using the quantile normalization method30. The
microarray data were deposited to the gene expression
omnibus (GEO) database (Accession ID: GSE94506).
Statistical analysis of gene expression data
We identiﬁed differentially expressed genes (DEGs)
from the three comparisons (MDSC vs. MEF, iMSC vs.
MEF, and sort-iMSC vs. MEF) using a previously reported
statistical test31. Brieﬂy, a T-value was computed for each
gene. An empirical distribution of the null hypothesis (i.e.,
a gene is not differentially expressed) was estimated by
calculating T-values for the genes after randomly per-
muting the samples and by applying the Gaussian density
estimation method to the T-values obtained from the
random permutations. For each gene, the adjusted P-value
was computed by performing the two-tailed T-test for its
T-value using the empirical null distribution. DEGs were
selected as the genes with (1) adjusted P-values ≤ 0.05 and
2) absolute log2-fold-changes ≥ 1. Finally, the enrichment
analysis of gene ontology biological processes (GOBPs)
was performed for a list of genes using DAVID software32
and the GOBPs represented by the genes were identiﬁed
as those with the enriched P-values < 0.05 (EASE test in
DAVID).
Network analysis
To build a network model for muscle differentiation
deﬁned by iMSCs and sort-iMSC cells, we ﬁrst selected
the cell cycle- and differentiation-related GOBPs repre-
sented by the DEGs. We then obtained the DEGs involved
in these processes and identiﬁed KEGG pathways repre-
sented by such DEGs: Calcium, Jak-STAT, MAPK, Notch,
TGF-ß, VEGF, and Wnt signaling pathways, as well as the
pathway for the regulation of the actin cytoskeleton. Next,
we built a network model describing the interactions
among the DEGs involved in these pathways using
interaction data in the KEGG pathways and also
protein–protein interactions (PPIs) collected from the
following PPI databases: the Biological General Repository
for Interaction Datasets (BioGRID)33, the Database of
Interacting Proteins (DIP)34, High conﬁdence
protein–protein interactions (HitPredict)35, the IntAct
molecular interaction database (IntAct)36, the Molecular
INTeraction database (MINT)37, and functional protein
association networks (STRING)38. The nodes in the net-
work model were arranged into the above pathways based
on the information in the KEGG pathway database.
Statistical analysis
All values are presented as the mean ± S.E.M. Statistical
analyses were determined using one-way analysis of var-
iance (ANOVA) followed by Tukey’s multiple comparison
tests. The value of statistical signiﬁcance was set at *P <
0.05, **P < 0.01, or ***P < 0.001.
Results
Combination of four TFs is critical to establish iMSCs
To induce the direct conversion of ﬁbroblasts to myo-
genic stem cells, we selected ten TFs, MyoD, Lin28, Pax3,
Eya1, Bmi1, Esrrb, Lbx1, Ezh2, Dppa2 and Six1, that are
known to be important for myogenic development and
stem cell function and tested the function of the TFs in
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the direct reprograming of myogenic stem cells from
MEFs. Among them, we found the combination of four
master TFs (that will be noted 4F), Six1, Eya1, Esrrb and
Pax3, reprogramed MEFs into myogenic stem cells.
To identify key TFs that reprogram MEFs into myo-
genic stem cells among the four TFs, we transduced
MEFs with only three of the four TFs: 4F-Six1 repre-
sented cells transduced with four transcriptional factors
minus Six1 (Eya1, Esrrb, Pax3), 4F-Esrrb represented
cells transduced with four transcriptional factors minus
Esrrb (Six1, Eya1, Pax3), 4F-Eya1 represented cells
transduced with four transcriptional factors minus Eya1
(Six1, Esrrb, Pax3) and 4F-Pax3 represented cells
transduced with four transcriptional factors minus Pax3
(Six1, Eya1, Esrrb). We evaluated the expression level of
myogenic factors of the transduced cells by real-time
PCR and IF. In real-time PCR analysis, 4F-Six1 and 4F-
Esrrb showed extremely low expression of Pax7, Myf5
and MyoD, which were similar to those of MEFs grown
in myogenic growth media. 4F-Eya1 also expressed low
levels of myogenic genes. However, Pax7, Myf5 and
MyoD were highly expressed in both 4F-Pax3 and 4F.
Additionally, 4F-Pax3 showed higher expression than
4F, except for Myf5 (Fig. 1a–c).
These real-time RT-PCR results were coincided with
those of IF. According to the IF of Pax7 and MyoD, no or
only a few Pax7- and MyoD-positive cells were observed
in 4F-Six1 (Pax7 0%, Myf5 0%, MyoD 0%), 4F-Esrrb (Pax7
0%, Myf5 0%, MyoD 0%), and 4F-Eya1 (Pax7 8%, Myf5
10%, MyoD 16%). However, both 4F-Pax3 and 4F had a
lot of positive cells for Pax7, Myf5, and MyoD. However,
both 4F-Pax3 and 4F showed large numbers of cells
positive for Pax7, Myf5, and MyoD. 4F-Pax3 showed 42%
of Pax7-positive cells and 57% of MyoD-positive cells. 4F
showed 31% of Pax7 positivity and 35% MyoD positivity.
4F-Pax3 showed higher expression of Pax7 and MyoD
compared to 4F. However, the expression of Myf5 was
higher in 4F (62%) than in 4F-Pax3 (38%) (Fig. 1d).
Interestingly, 4F-Pax3 showed minimal differentiation
into muscle ﬁbers when incubated in myogenic differ-
entiation media (DM) for 15 days (Fig. 1e), although early
myogenic differentiation markers (Pax7, Myf5, and
MyoD) were highly expressed in 4F-Pax3 (Fig. 1a–d).
Most 4F-Pax3 cells died in 1 week during incubation in
DM, while the viability of 4F was high under the same
myogenic DM condition (Fig. 1e). Only a few surviving
4F-Pax3 cells elongated and formed myotubes in myo-
genic DM. We plate the same number of cells on 2 well
chamber slides and wait until the conﬂuency reached 90%.
When the cell conﬂuency reached 90%, we incubate each
cells in myogenic differentiation media. Thus, the initial
cell number of 4F and 4F-Pax3 was same. However almost
60% of the initial cells were disappeared during the
medium exchange.
The 4F cells elongated and fused together to form
myotubes in myogenic DM (Fig. 1e). After incubation in
myogenic DM, 4F showed numerous MHC-positive
cells, while 4F-Pax3 showed a few MHC-positive cells
(Fig. 1f). Without Pax3, the transduced cells could not
differentiate into muscle ﬁbers, although Pax7, Myf5,
and MyoD expressions were high, suggesting that the
four factors are necessary for giving myogenic differ-
entiation capacity.
Establishment of iMSCs with myogenic potentials
After transduction of the four TFs, we isolated single-
cell colonies, since it is hard to distinguish myogenic stem
cells from MEFs by morphology. Among the 99 single-cell
lines, we sorted out 22 single-cell lines showing high
expression of both Pax7 and Myf5. To clarify the myo-
genic differentiation capacity in vitro, we incubated each
single-cell line in myogenic differentiation media. The
nine single-cell lines among the 22 of Myf5+ lines
represented high myogenic differentiation capacity
showing multinucleated muscle ﬁbers. We refer the cells
as induced myogenic stem cells (iMSCs). The established
iMSCs were positive for Pax7 (55.83%), Myf5 (44.53%),
and MyoD (56.28%) in IF (Fig. 2b). And all the Pax7-
positive cells were positive for Myf5 (Fig. 2c). The four
TFs were integrated stably into the genome of iMSCs and
expressed at the protein level (Fig. 2d, e). The karyotype of
iMSCs was normal (Fig. 2f).
iMSCs are more proliferative than MDSCs and MEFs
Prolonged proliferation of stem cells in vitro is a key
feature for the therapeutic purpose of stem cells. We,
therefore, measured the proliferation capacity of iMSCs.
When we compared the cell growth curve of iMSC at
early (P12) and late (P50) passages, iMSCs at each two
passages showed no difference in their proliferation
capacity (Fig. 3a). The doubling time also had no sig-
niﬁcant difference between the two passages (p= 0.322),
suggesting that the iMSCs are stably expandable without
losing their proliferative capacity though the passage
number is increased (Fig. 3b).
When we compare the proliferation capacity of iMSCs
to that of MDSCs and MEFs, the iMSCs showed higher
proliferation capacity than the others. To measure the
proliferation capacity, we seeded 3 × 104 of MEFs,
MDSCs, and iMSCs in each well and counted the number
of cells every 24 h. After 72 h of incubation, the number of
iMSCs was 98.25 × 104 ± 8.66, while the numbers of MEFs
and MDSCs were 12.92 × 104 ± 5.83 and 49.17 × 104 ±
2.79. Thus, these data indicate that iMSCs have higher
proliferation capacity than MDSCs and MEFs (Fig. 3c).
Additionally, the doubling time of iMSCs (16.76 h) was
shorter than MEFs (27.08 h) and MDSCs (21.16 h)
(Fig. 3d).
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Fig. 1 Comparison of expression levels of myogenic factors in N-1 study. a–c Real-time RT-PCR of Pax7, Myf5, and MyoD. d IF against Pax7, Myf5,
and MyoD in N-1 study. Scale bar= 40 µm. e Phase contrast images of 4F-Pax3 and 4F before and after incubation in differentiation media for
15 days. Upper scale bar= 250 µm. Lower scale bar= 500 µm. f IF against MHC in 4F-Pax3 and 4F after incubation in differentiation media for
15 days. Scale bar= 40 µm. White arrow heads indicate MHC-positive muscle ﬁbers. Each myogenic marker is represented in red. Nuclei are shown in
blue stained by DAPI. g The number of MHC-positive cells in 4F-Pax3 and 4F after incubation in differentiation media for 15 days. One-way ANOVA
was used for statistical analysis. Data are shown as the mean ± S.E.M. (***P < 0.001)
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When we evaluated the cell cycle of iMSCs, 70.09% of
iMSCs were at G0/G1 phase, which was higher than the
proportions of MDSCs (60.61%) and MEFs (61.84%) at
G0/G1 phase, whereas the proportions of iMSCs at the S
phase and G2/M phase were 6.82% and 22.78%, respec-
tively, which were relatively low (Fig. 3e).
To investigate a high proliferation capacity of iMSCs,
we evaluated the expression of ﬁbroblast growth factor
receptor1 (FGFR1) and growth factor receptor bound
protein 2 (GRB2) in iMSCs. According to real-time RT-
PCR, iMSCs showed signiﬁcantly higher expression of
FGFR1 than MEFs and MDSCs (***P < 0.001) (Fig. 3f).
Also, iMSCs showed higher mRNA and protein levels of
GRB2 than MEFs and MDSCs (Fig. 3g–i).
More myogenic iMSCs can be further enriched by CD106-
negative and α7-integrin-positive fraction
To enhance myogenic differentiation capacity, we sor-
ted the iMSCs with the cell surface markers, CD106 and
α7-integrin, based on the FACS analysis results (Fig. S1).
A subset of iMSCs was found to be CD106 ( - ) and α7-
integrin (+ ) (14 ± 2.14 %) (Fig. 4a). We referred to these
as sort-iMSCs. When we maintained the iMSCs and sort-
iMSCs in growth media, the sort-iMSCs were more
Fig. 2 Establishment of iMSCs. a Scheme of establishment of iMSCs from mouse embryonic ﬁbroblasts. MEF mouse embryonic ﬁbroblast, Six1-MEF
Six1 transduced MEFs, 4TF-MEF 4TFs (Six1, Eya1, Esrrb, and Pax3) transduced MEFs; iMSC induced myogenic stem cells. b IF of Pax7, Myf5, and MyoD.
Each myogenic marker is represented in red. Nuclei are shown in blue stained by DAPI. Scale bar= 40 µm. c Co-staining of Pax7 and Myf5. Pax7 is
represented in green and Myf5 is represented in red. Scale bar= 20 µm. d Genome integration test. All the size of the bands is 200 bp. The gel
images were cropped and aligned. e Immunoblotting of transduced factors—Six1 (37 kDa), Eya1 (65 kDa), Esrrb (55 kDa), Pax3 (58 kDa), and GAPDH
(37 kDa). The blot images were cropped and aligned. All the four factors were expressed in protein level. f Karyotype analysis of iMSCs. The iMSCs
showed a normal karyotype (38, XY)
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refractive and smaller than iMSCs. In 1 day after incu-
bation of sort-iMSCs in myogenic DM, the cells began to
elongate and fuse together, causing the nucleus to come
into line. In 3 days after incubation in myogenic DM, sort-
iMSCs formed multinucleated branch-shaped myotubes.
The iMSCs also showed such differentiation in myogenic
DM, but only a limited differentiation to few multi-
nucleated myotubes, which are a late myogenic differ-
entiation marker (Fig. 4b).
To clarify the myogenic differentiation capacity of
iMSCs and sort-iMSCs, we compared the expression of
Pax7, Myf5, MyoD, myogenin, and MHC under both
proliferation and differentiation conditions. Both iMSCs
and sort-iMSCs showed high expression levels of Pax7
comparable to MDSCs in proliferation media. Both
iMSCs and sort-iMSCs showed higher expression of
Myf5, MyoD, myogenin, and MHC in proliferation media
than MEFs, but lower expression than MDSCs (Fig. 4c–e).
On the other hand, sort-iMSCs showed higher expression
of myogenin and MHC than iMSCs, although iMSCs and
sort-iMSCs showed similar expression of Pax7, Myf5, and
MyoD (Fig. 4c). We maintained the cells in myogenic DM
for 3 days. In 3 days after incubation in DM, sort-iMSCs
showed higher expression of all the myogenic regulatory
genes except Myf5 compared to iMSCs. Additionally,
sort-iMSCs showed comparable expression of Myf5 and
myogenin to MDSCs in DM (Fig. 4d–f). Additionally,
sort-iMSCs showed comparable expression of Myf5 and
myogenin to MDSCs in DM (Fig. 4d–f). Taken together,
iMSCs showed upregulation of early myogenic regulatory
factors including Pax7, Myf5, and MyoD in proliferation
media. In myogenic differentiation media, sort-iMSCs
showed upregulation of late myogenic regulatory factors
including myogenin and MHC. Thus, sort-iMSCs exhib-
ited higher myogenic differentiation capacity than iMSCs.
To clarify the reason for higher myogenic differentiation
capacity of sort-iMSCs, we checked the expression of
ERR-α and ERR-γ, known as regulators of myogenic dif-
ferentiation through regulation of mitochondrial biogen-
esis in skeletal muscle39. ERR-γ and ERR-α in sort-iMSCs
Fig. 3 Proliferation capacity of iMSCs. a Cell growth curve of early and late passages of iMSCs. Early passage= P12, Late passage= P50. b
Doubling time of early and late passages of iMSCs. Early passage= P12, Late passage= P50. c Cell growth curve of MEFs, MDSCs, and iMSCs. d
Doubling time of MEFs, MDSCs, and iMSCs. e Cell cycle analysis using FACS. f, g Gene expression levels of FGFR1 and GRB2 measured by real-time RT-
PCR. h, i Immunoblotting of GRB2 (31 kDa). Normalization was performed with ß-tubulin (55 kDa). The blot images were cropped and aligned. Image
J was used for quantiﬁcation of immunoblotting bands. One-way ANOVA was used for statistical analysis followed by Tukey’s multiple comparison
test (***P < 0.001, **P < 0.01). Data are shown as the mean ± S.E.M. P passage
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were upregulated in DM condition, compared to iMSCs
(Fig. 4g, h). The increased expression of ERR-γ and ERR-α
in sort-iMSCs indicates that sort-iMSCs are more potent
in oxidation, leading to upregulation of myogenic reg-
ulatory factors, including myogenin, and myogenic
differentiation.
Sort-iMSCs restore more dystrophin than MDSCs and MEF
in mdx mice
So far, we checked the characteristics of iMSCs and
sort-iMSCs in vitro. We evaluated myogenic differentia-
tion capacity of sort-iMSCs in vivo, since sort-iMSCs
showed more potent myogenic differentiation capacity
than iMSCs in vitro. To evaluate myogenic differentiation
of sort-iMSCs in vivo, we injected the cells into mdx mice
that do not express dystrophin. In 4 weeks after cell
injection, the sort-iMSCs injected muscles were regener-
ated and appeared normal in gross ﬁndings without any
neovascularization and granulation tissue (Fig. 5a). The
sort-iMSCs transplanted-TA muscle contained
dystrophin-positive muscle ﬁbers, whereas either MEFs or
MDSCs transplanted-TA muscle showed few or only a
few dystrophin-positive ﬁbers. These data indicate that
the injected sort-iMSCs were engrafted successfully, sur-
vived in the injured muscle, and differentiated into muscle
ﬁbers. We conﬁrmed that the myogenic differentiation
capacity of sort-iMSCs was higher than MEFs and
MDSCs in vivo (Fig. 5b, c). In H&E staining, we detected
calciﬁcation area (arrow heads in Fig. 5c) in all the notexin
injected-mdx mice except sort-iMSCs group. Reduced
calciﬁcation area in sort-iMSCs group represents that
more recovery of damaged muscle cells is achieved in
sort-iMSCs group than other group (Fig. 5c). In Azan
staining, unlike deep-blue stained MDSC injected group,
the sort-iMSCs injected group showed weak stainability
representing less collagen ﬁbers produced in sort-iMSCs
injected group. None of the injected mice showed
apparent immune reactions and inﬁltration of inﬂamma-
tory cells (Fig. 5c).
iMSCs are more proliferative than MDSCs in mdx mice
To evaluate the early engraftment and proliferation of
iMSCs in vivo, we transplanted Tomato+ iMSCs (5 × 104
cells/mouse) or iRFP+MDSCs (5 × 104 cells/mouse as a
control) into injured muscles and track them in vivo real-
time by using an intravital imaging system sequencially.
At 7 days after transplantation, the Tomato+ iMSCs
engrafted successfully and aligned with exiting ﬁbers were
observed. Sequential intravital imaging at 14 and 21 days
after transplantation revealed that the number of trans-
planted tomato+ iMSCs was increased and they incor-
porated into regenerating ﬁbers at 21 days, indicating
iMSCs are transplantable and retain their myogenic ability
even after transplantation in vivo in injured muscle. The
engraftment efﬁciency and in vivo proliferation capacity
were much higher in iMSCs compared to in MDSCs
(Fig. 5d). Because of the high proliferation capacity of
iMSCs in vivo, we evaluated whether the iMSCs have
tumorigenicity. No tumor mass was observed in iMSCs
injected mice, whereas iPSC-injected nude mice showed
teratoma in 3 weeks (Fig. 5e). We conﬁrmed that the
iMSCs did not induce tumor formation when injected
in vivo.
Genome-wide mRNA expression analysis of iMSCs and
sort-iMSCs
To understand the molecular nature underlying differ-
entiation and proliferation capacity of iMSCs and sort-
iMSCs, we performed genome-wide gene expression
proﬁling of MDSCs, MEFs, iMSCs, and sort-iMSCs using
the Agilent SurePrint G3 mouse GE 8 × 60 K microarray.
Using the gene expression proﬁles, we identiﬁed a total of
5,111 differentially expressed genes (DEGs) from the fol-
lowing three comparisons: (1) MDSC vs. MEF (3,543
DEGs with 1560 upregulated and 1983 downregulated),
(2) iMSCs vs. MEF (2,687 DEGs with 1,064 upregulated
and 1,623 downregulated), and (3) sort-iMSCs vs. MEF
(3,486 DEGs with 1,382 upregulated and 2,104 down-
regulated) (Fig. 6a and Supplementary Table S1). To
systematically explore these DEGs, we categorized them
into 23 clusters (C1-23; Supplementary Table S2) based
on their up- and downregulation in the tree comparisons.
Of them, we focused on 10 clusters (C1 and C4-12)
showing differential expression in the two comparisons of
iMSCs vs. MEFs and sort-iMSCs vs. MEFs. These 10
clusters were further grouped into six groups (G1-6)
based on their up- and downregulation patterns in the
two comparisons (Fig. 6b and Supplementary Table S1).
(see ﬁgure on previous page)
Fig. 4 Comparison of iMSCs and sort-iMSCs in both GM and DM. a FACS sorting of iMSCs using CD106(–) and α7-integrin(+). b Phase contrast
images of iMSCs and sort-iMSCs. iMSCs and sort-iMSCs were maintained in proliferation or myogenic differentiation media. Yellow arrows indicate
multinucleated ﬁbers, indicating late-stage muscle differentiation in vitro. Scale bar= 500 µm. c Gene expressions of MEF, MDSCs, iMSCs, and sort-
iMSCs under GM. d Gene expressions of MEF, MDSC, iMSCs, and sort-iMSCs under DM. e IF for Pax7, Myf5, MyoD, myogenin, and MHC of iMSCs and
sort-iMSCs in GM. f IF for Pax7, Myf5, MyoD, myogenin, and MHC of iMSCs and sort-iMSCs in DM. Each myogenic marker is represented in red. Nuclei
are shown in blue stained by DAPI. Scale bar= 40 µm. g, h Expression levels of ERR-α and ERR-γ of iMSCs and sort-iMSCs in GM and DM measured by
real-time RT-PCR. Data are shown as the mean ± S.E.M (***P < 0.001, **P < 0.01, *P < 0.05). GM growth media, DM differentiation media
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G1 and G5 comprised clusters up- and downregulated in
iMSCs, respectively, but not in sort-iMSCs, compared to
MEFs, whereas G3 and G6 comprised clusters up- and
downregulated in sort-iMSCs, respectively, but not in
iMSCs. G2 and G5 comprised clusters up- and down-
regulated commonly in both iMSCs and sort-iMSCs,
respectively.
To understand the cellular processes associated with
G1-6, we performed the enrichment analysis of GOBPs
for the genes in G1-6 using DAVID software (Fig. 6c and
Supplementary Tabls S3). G1 upregulated in iMSCs,
compared to MEFs, signiﬁcantly (P < 0.05) represented
cell cycle-related processes (cell cycle and mitotic cell
cycle), wherease G4 downregulated in iMSCs represented
apoptosis-related processes (programmed cell death and
apoptosis). Interestingly, of these processes, only the
apoptosis-related processes were represented by the
downregulated genes in MDSCs, compared to MEFs, but
the cell cycle-related were represented by neiether the up-
nor downregulated genes in MDSCs. Collectively, these
data suggest that iMSCs show higher proliferation capa-
city than MEFs and even than MDSCs, consistent to our
ﬁndings in Fig. 3c, d. Moreover, G3 and G5 up- and
downregulated in sort-iMSCs, respectively, compared to
MEFs, represented differentiation-related processes (tis-
sue morphogenesis, epithelial tube morphogenesis, blood
vessel development, bone development, and cell mor-
phogenesis). All of these processes were also represented
by the DEGs in MDSCs, compared to MEFs. These data
suggest that sort-iMSCs show differentiation capacity
compatible to MDSCs, which is consistent with our
ﬁndings shown in Fig. 4d. Moreover, two differentiation-
related processes (tissue and epithelial tube morphogen-
esis) were represented by G3, but by neither G1 nor G2,
consistent to enhanced differentiation capacity of sort-
iMSCs compared to iMSCs, consistent to our ﬁnding
in vitro shown in Fig. 4.
Network model describing signaling pathways associated
with enhanced proliferation and differentiation capacity of
iMSCs and sort-iMSCs
To examine the intracellular signaling pathways asso-
ciated with proliferation and differentiation capacity of
iMSCs and sort-iMSCs, we ﬁrst selected the DEGs
involved in the aforementioned cell cycle- and
differentiation-related cellular processes represented by
G1-G6 and then identiﬁed KEGG signaling pathways
represented by these DEGs. Next, we reconstructed a
network model describing the interactions among the
DEGs involved in these signaling pathways (Fig. 6d). First,
Notch and TGF-β signaling pathways were activated in
iMSCs and sort-iMSCs, as indicated by upregulation of
Notch3/4, Dll1, and Maml3 (Notch signaling) and Acvr2b,
Smad9, and Id1/2 (TGF-β signaling) in iMSCs or sort-
iMSCs, compared to MEFs. Second, Wnt and Jak-stat
signaling pathways were activated in iMSCs and sort-
iMSCs as indicated by upregulation of Wnt7b, Porcn,
CsnK1e, Btrc, Lef1, and Tcf7 (Wnt signaling) and Il2rg/b,
Il12rb1, Stam, Stat5a, and Socs2/7 (Jak-stat signaling) in
iMSCs or sort-iMSCs, compared to MEFs. These path-
ways are known to be involved in cell proliferation and/or
differentiation, suggesting their contirubtion to high
proliferation capacity of iMSCs (Fig. 3c) and high differ-
entiation capacity of sort-iMSCs (Fig. 5b). Third, FGF and
integrin signaling pathways were activated in iMSCs and
sort-iMSCs as indicated by upregulation of Fgf1/11/21
and Fgfr1 (Fgf signaling) and Itga3/6/7 and Itgb4/6/7
(Integrin signaling), as well as upregulation of down-
stream signaling molecules in the actin reorganization
pathway (Ptk2b, Grb2, Tiam1/2, Pak1, Parvb, and Vasp) in
iMSCs or sort-iMSCs, compared to MEFs. Finally, cal-
cium signaling was activated in iMSCs and sort-iMSCs as
indicated by upregulation of calcium transporters (Cac-
na1s/a2d1/b1/g1, Ryr1, and Atp2a1/2). The FGF, integrin,
and calcium signaling pathways are known to activate
myosins (Myh7/14 and Mylk2/pf), actins (Actc1/n2/n3)
and troponins (Tnnc1/2), suggesting their contribution to
morphological changes required for proliferation of
iMSCs and differentiation of sort-iMSCs. Collectively, the
network model suggests that these signaling pathways can
play key roles in conferring higher proliferation and dif-
ferentiation capacity to iMSCs and sort-iMSCs,
respectively.
Discussion
In this study, we established induced myogenic stem
cells (iMSCs) by ectopic expression of Six1, Eya1, Esrrb,
and Pax3. The iMSCs have myogenic differentiation
(see ﬁgure on previous page)
Fig. 5 Myogenic differentiation and proliferation capacity in mdx mice. a In vivo differentiation capacity of sort-iMSCs. Gross observation of cell-
transplanted T.A muscle of mdx mice. b The number of dystrophin-positive cells in IF staining against dystrophin. c IF staining against dystrophin
(upper panel). Representative images of transverse section of T.A muscle. Dystrophins are represented in red. Nuclei are shown in blue stained by
DAPI. Scale bar= 40 µm. Hematoxyline and eosin staining (middle panel). Arrow heads indicate calciﬁcation area. Scale bar= 100 µm. Azan staining
(lower panel). Scale bar= 100 µm. d In vivo proliferation capacity of iMSCs. Sequential images of TA muscle repair transplanted with 1 × 105 iMSCs or
MDSCs at 7, 14, and 21 days after transplantation. Collagen ﬁbrils of the muscle ﬁber are shown in blue. The transplanted cells are represented in red.
Arrow indicates regenerating ﬁber cells. Scale bar= 75 µm. e Tumor formation test of iMSCs in nude mice. WT wild type, iPSC induced pluripotent
stem cell
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capacity both in vitro and in vivo. Also, the iMSCs
represented higher proliferative capacity even than
MDSCs. The iMSCs indeed do not lose proliferative
capacity until the passage was up to 50 (Fig. 3a). The
ectopic expression of four TFs upregulates endogenous
myogenic regulatory genes.
To clarify the role of the four TFs in the establishment
of iMSCs, we transduced MEFs with three transcriptional
factors omitting one of the four factors. Six1 and Esrrb
play a pivotal role in converting MEFs to myogenic stem
cells. Without six1 or esrrb, the increase of pax7, myf5,
and myoD was minimal and establishment of iMSCs was
hard to achieve (Fig. 1a–d). It is studied that Pax3 and
Pax7 are key factors that confer early myogenic capacity
leading to myotome during mouse muscle development23.
However, overexpression of Pax3, without Six1 or Esrrb,
is not sufﬁcient to upregulate Pax7 and convert MEFs to
myogenic lineage cells in 4F-Six1 and 4F-Esrrb.
The expression of myogenic factors was slightly
increased in 4F-Eya1. Eya1 has dual role as a protein
tyrosine phosphatase and transcriptional cofactor40. Eya1
acts as phosphatase and turns on Six1 from repression to
activation19,40. Without Eya1, Six1 cannot function as
much as interacting with Eya1. The interaction of Six1
and Eya1 directly activates Pax3 in limb muscle devel-
opment, suggesting that the expression of Six1 and Eya1
increase the expression of Pax318,19.
Interestingly, 4F-Pax3 cells represented higher expres-
sion in Pax7 than 4F cells, while similar expression was
observed for MyoD and lower for Myf5 (Fig. 1a–d). The
increase of Pax7 in 4F-Pax3 may be caused by the inter-
action of Six1 and Eya1. However, without Pax3, the cells
could not differentiate into myotubes, even when myo-
genic expressions were increased (Fig. 1). Pax7, a para-
logue of Pax3, can substitute for Pax3 because it shares
most myogenesis functions with Pax3, including the
regulation of MyoD41. Although the increased expression
of Pax7 in 4F-Pax3 can replace ectopic Pax3 in terms of
regulating myogenic factors including Myf5 and MyoD
under the proliferation condition, it is not enough to
trigger myogenic differentiation.
The increased expression of Pax7 may explain the
insufﬁciency of muscle differentiation of 4F-Pax3 in the
differentiation environment (Fig. 1e, f). For muscle dif-
ferentiation, Pax7 expression must be downregulated42.
Activated satellite cells undergo sequential processes of
proliferation, downregulation of Pax7, and then differ-
entiation into muscle ﬁbers. Pax7 activates proliferation of
satellite cells but delays the expression of myogenin
leading to delays of differentiation42. Particularly, during
Myf5 expression, which is the determinant of myogenesis,
4F cells shows higher expression level than 4F-Pax3, as
Myf5 is the direct target of Pax324. To differentiate into
muscle ﬁbers, the cells needs proper cell number and
conﬂuency to connect adjacent cells. The myogenic dif-
ferentiation media contains minimum nutrients and the
only the cells with myogenic differentiation potential can
be survived in that such a harsh niche. The cells that do
not survive in the myogenic differentiation medium, like
4F-Pax3, are cells that lack the ability to differentiate into
muscle functionally.
Thus, all the four factors are necessary to induce myo-
genic stem cells, which have myogenic differentiation
capacity in DM not only express myogenic factors.
Without one of the four TFs, MEFs could not convert into
myogenic stem cells which express myogenic regulatory
factors and differentiate into myogenic ﬁbers under dif-
ferentiation condition. Various combinations of candidate
TFs can be used to induce direct conversion into myo-
genic stem cells. Naoki et al.14 suggested that the com-
bination of six transcription factors induce direct
reprogramming of skeletal muscle progenitors from
(see ﬁgure on previous page)
Fig. 6 Comparison of genome-wide mRNA expression of MDSCs, MEFs, iMSCs, and sort-iMSCs. Differentially expressed genes in iMSCs and
sort-iMSCs and their associated cellular processes and signaling pathways. a Relationship between the DEGs from the three comparisons, MDSCs vs.
MEFs (3543 DEGs), iMSCs vs. MEFs (2687 DEGs), and sort-iMSCs vs. MEF (3486 DEGs). b Differential expression patterns of the DEGs in the six groups
(G1-6). Numbers in parenthesis denote the sizes of the DEGs in the corresponding groups. Colors in the heat map represent up- (red) and
downregulation (green) of the genes (rows in the heat map). Color bar, gradient of log2-fold-changes of DEGs in the three comparisons. The
dendrogram was generated by performing a hierarchical clustering of the log2-fold-changes of DEGs in the three comparisons (Euclidean distance as
a dissimilarity measure and complete linkage). c GOBPs represented by the DEGs in G1-6, as well as upregulated (MDSCs up) and downregulated
(MDSCs down) genes in MDSCs, compared to MEFs. Color gradient represents the signiﬁcance, -log10(P-value), of the corresponding GOBPs being
enriched by the DEGs in G1-6, MDSC up and MDSC down, where P-value is the enrichment P-value computed by DAVID. Font colors of GOBP labels
represent groups of GOBPs: red, cell cycle-related processes represented by DEGs in iMSCs, but not by DEGs in sort-iMSCs; green, differentiation-
related processes represented by DEGs in sort-iMSCs, but not by DEGs in iMSCs; and blue, cell cycle and differentiation-related processes represented
by DEGs in both iMSCs and sort-iMSCs. d Signaling network model associated with proliferation and differentiation of iMSCs and sort-iMSC cells.
Node and node border colors represent log2-fold changes of their corresponding genes in iMSCs vs. MEFs and sort-iMSCs vs. MEFs, respectivly. Color
gradient represents log2-fold-changes of DEGs in the comparisons indicated in the legend (box at bottom right). The edges represent direct
activation (arrows), repression (inhibition symbols), indirect activation through intermediate molecules not shown (dotted line) and PPIs (gray solid
line), respectively. The types of interactions were obtained from the KEGG pathway database. Plasma membrane is denoted as the thick blue lines
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embryonic ﬁbroblasts. However, the combination of TFs
for direct conversion should be accurate because it is very
delicate. Induction with or without one speciﬁc TF can
trigger reprogramming of totally different type of cells.
For example, without Pax3, in this study, the cells repre-
sented proliferative capacity with weak myogenic differ-
entiation. Thus, accurate combination of TFs is important
to establish myogenic stem cells with both proliferation
and myogenic differentiation capacities.
The established iMSCs with the four factors represented
high expression levels of early myogenic regulatory factors
including Pax7, Myf5, and MyoD (Fig. 2b). Interestingly,
iMSCs represent even 1.38 times higher Pax7 expression
than MDSCs and 7,634 times higher than MEF (P <
0.001). Compared with the fact that <30% of MDSC is
Pax7-positive, about 55.83% of iMSCs are positive for
Pax7, which is quite high expression43. Pax7 promotes
self-renewal of satellite cells and maintains the satellite
cell pool44. It is revealed in Pax7 mutant mice that Pax7
have anti-apoptotic function41. Also, repressed expres-
sions of late differentiation markers including myogenin
and MHC enhanced the proliferation of iMSCs under
proliferation condition. Thus, the increased expressions of
early myogenic factors are related to the high proliferation
capacity of iMSCs. Additionally, iMSCs are expandable up
to passage 90 (data not shown). This is a major difference
between iMSCs and MDSCs. The low expressions of
myogenin and MHC maintain the elevated expression
levels of Pax7 and Myf5 and proliferation capacity in GM
condition.
In the FACS analysis, the iMSCs showed distinct
expression patterns with MDSCs except for α7-integrin.
The iMSCs were strongly positive for α7-integrin (97.23 ±
0.43 %) which is compatible to satellite cells. α7-integrin is
one of the most well-known cell surface markers of
satellite cells and myoblasts45. α7-integrin can be used to
distinguish myoblasts from ﬁbroblasts46. Te iMSCs were
intermediately positive for CD34 (14.20 ± 2.92%) and
Syndecan 4 (7.57 ± 3.56%) (Fig. S1). Satellite cells are
positive for α7-integrin, CD34, CXC motif reception R-4
(CXCR) and CD106 and negative for CD45, CD31,
CD11b, and Sca-147–49. The iMSCs can be distinguished
from satellite cells based on their reactivity against CXCR,
CD34, CD106, and Sca-1. Although iMSCs showed
myogenic differentiation capacity, the cells differed from
satellite cells in terms of cell surface markers.
Interestingly, the FACS analysis of iMSCs revealed two
distinct peaks for CD106, Sca-1, and CD73, indicating
that the cells were composed of two populations (Fig. S1).
All the three markers are mesenchymal stem cell mar-
kers50,51, suggesting that the cells contained both
mesenchymal stem cell stage- and non-mesenchymal
stem cell stage-populations. We revealed that sorting with
α7-integrin and the absence of CD106 increased both the
myogenic differentiation capacity and myogenic reg-
ulatory factor gene expressions (Fig. 4). It has been
revealed that FACS sorting with speciﬁc cell surface
markers enhances the myogenic differentiation capacity52.
We compared the myogenic capacity of iMSCs and
sort-iMSCs under both proliferation and differentiation
condition. The iMSCs exhibited a spindle-shaped cyto-
plasm and round nucleus, which were similar to
mesenchymal stem cells in proliferation media. The sort-
iMSCs showed robust myogenic differentiation capacity
when incubated in myogenic differentiation media for
3 days (Fig. 4b). In the myogenic differentiation media, the
sort-iMSCs represented higher expressions of myogenic
regulatory factors than iMSCs, excepting for Myf5
(Fig. 4d). Particularly, myogenin expression in sort-iMSCs
increased signiﬁcantly, comparable to MDSCs. Down-
regulation of Myf5 in sort-iMSCs may lead to upregula-
tion of late myogenic differentiation factors including
MyoD, myogenin, and MHC in DM. Thus, the sort-
iMSCs may be more reactive to the myogenic differ-
entiation niche than iMSCs, considering that they share
similar myogenic expression pattern in proliferation
media (Pax7, Myf5, and MyoD in Fig. 4c), but completely
different expression in differentiation media (Fig. 4d). It
suggests that the sort-iMSCs have greater myogenic dif-
ferentiation capacity than iMSCs. Thus, we obtain enough
number of iMSCs in myogenic growth media and sort the
cells using the cell surface markers when we apply in vivo
test or check myogenic differentiation capacity.
The high myogenic differentiation ability of sort-iMSCs
may be related to its increased expression of ERR-γ and
ERR-α in DM (Fig. 4g, h). In the previous study, muscle
speciﬁc ERR-γ –/– represented immature myotube for-
mation39. It is revealed that increase of mitochondrial
biogenesis is needed to induce myogenic differentiation53
and ERR-γ increased mitochondrial activity and oxidative
capacity in skeletal muscle54. And ERR-α regulates myo-
genic differentiation cooperating with PGC-1α, which is
one of master regulator of mitochondrial biogenesis in
skeletal muscle55–57.
We evaluated the myogenic differentiation properties of
sort-iMSCs in vivo. The sort-iMSCs differentiated into
myotubes and expressed dystrophin when transplanted
into mdx mice (Fig. 5a–c). It suggests that the sort-iMSCs
can be successfully engrafted, survive, and differentiate
into myotubes in vivo. Although satellite cells injected-
mdx mice showed a few dystrophin-positive ﬁbers, the
number was much smaller than sort-iMSCs injected one.
Sort-iMSCs injection restored more dystrophin (+) ﬁbers
than MEFs or MDSCs in mdx mice indicating that the
sort-iMSCs are more potent than MEFs and even MDSCs
when transplanted in vivo (Fig. 5c). In most studies,
researchers destroy the endogenous satellite cells of the
recipient mdx mice through the 18G irradiation, and then
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transplant satellite cells or myoblasts into the muscle of
recipient58,59. This can avoid competition between endo-
genous satellite cells and exogenous muscle stem cells,
and maximize the engraftment efﬁciency of transplanted
cells. However, in the case of depleting satellite cells by
irradiation, it cannot be said that the experiments in
which the intramuscular environment is reproduced since
all the endogenous satellite cells have been destroyed.
Therefore, in this study, we evaluated the ability of sort-
iMSCs to survive competition with existing endogenous
satellite cells without irradiation. Thus, the positive con-
trol, MDSCs, represent lower levels of dystrophin than in
previous studies which deplete the endogenous satellite
cells in mdx47,60,61. Consider that we do not irradiate the
mdx mice, sort-iMSCs can be survived in the environ-
ment which have been already occupied by endogenous
satellite cells.
We established induced myogenic stem cells through
ectopic expression of Six1, Eya1, Esrrb and Pax3. In
contrast, Ito et al. established the induced skeletal muscle
progenitor cells (iSkMs) through ectopic expression of a
transcriptional factors including Pax314. There is a clear
difference between induced muscle progenitor cells and
induced muscle stem cells. The cell fates of muscle stem
cell are proliferation and/or muscle differentiation,
whereas the cell fate of muscle progenitor is muscle dif-
ferentiation. In this study, we conﬁrmed robust pro-
liferation or iMSCs different from previous iSkMs, and it
was conﬁrmed that the proliferative capacity was main-
tained even after the passage, and that it was a muscle
stem cell in which differentiated into muscle cells.
The proliferative capacity of iMSCs is superior to
MDSCs. The proliferation capacity of MDSCs is low and
the proliferation rate is getting slower as the passage
number is increased, since they are primary cells. In the
proliferation assay, iMSCs represent higher proliferation
capacity than MDSCs both in vitro and in vivo (Figs. 3 and
5c). To reveal the involved mechanisms, we checked FGF
signaling which is well-known for its function in cell
proliferation62. Interestingly, the expression of FGFR1 was
much higher than in both MEFs and MDSCs (***P <
0.001) (Fig. 3f). In myoblast, proliferation is decreased by
the repression of FGFR1 through KLF1063. FGFR1 pro-
motes the proliferation of stem cells through cyclin-
dependent kinase inhibitors64,65. It is consistent to our cell
cycle data that iMSCs showed high percentage of G0/G1
(Fig. 3e). In this study, the expression of GRB2 was
increased in iMSCs (Fig. 3g–i). Further studies are needed
to reveal the relationship between proliferation, GRB2,
and FGF signaling.
Because of the use of monocystronic vectors, ectopic
expression of many genes can create various cell popu-
lations. To exclude this possibility, single-cell sorting was
performed in this experiment. Each cell line was derived
from each cell. Although the iMSC is originated from a
single-cell, the iMSC has a heterogeneous characteristic as
it continues to pass, suggesting that the iMSC undergoes
asymmetric division like satellite cell. This was conﬁrmed
by cell morphology and FACS analysis (Fig. S1).
In this study, we established stably expandable induced
myogenic stem cells with four deﬁned factors. Especially,
the iMSCs have much higher proliferation capacity than
MDSCs. The established cells have both myogenic dif-
ferentiation capacity and robust proliferation properties.
The iMSCs can differentiate and form myotubes in vivo
without tumor formation. The stably expandable iMSCs
established in this study provide new source for drug
screening and muscle regenerative therapy.
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